EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Vedolizumab for De Novo Ulcerative Colitis After Kidney Transplantation in a Patient With IgA Nephropathy: A Case Report

Monica Cojocaru, Mona Dumbravă, Bogdan Marian Sorohan iD

Case Reports in Transplantation · 2026-01 · 2026 (1)

DOI: 10.1155/crit/3572812 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Transplantation, online erschienen am 14.07.2026. Verfasst von Monica Cojocaru und 2 weiteren Autor:innen. Beteiligte Einrichtung: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, umfcaroldavila.ro. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

De novo inflammatory bowel disease (IBD) is a rare but important cause of diarrhea after kidney transplantation (KT). Experience with newer biological agents in the management of IBD among KT recipients remains limited. Vedolizumab is an α 4 β 7 integrin antagonist that selectively blocks a subset of gastrointestinal‐homing lymphocytes, which limits systemic immunosuppression and, compared to other biologic agents or novel molecules, may reduce the risk of overimmunosuppression in the setting of KT. We report the case of a KT recipient with IgA nephropathy as the underlying cause of chronic kidney disease, who developed de novo ulcerative colitis after KT and was successfully treated with vedolizumab without experiencing adverse reactions during the 29 months of follow‐up.

Schlagwörter

Stichwörter der Autor:innen

kidney transplantationtreatmentulcerative colitisvedolizumab

Autor:innen und Institutionen

  • Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, umfcaroldavila.ro.
  • Department of Gastroenterology, Fundeni Clinical Institute, Bucharest, Romania, icfundeni.ro.
  • Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania, icfundeni.ro.
  • Department of Kidney Transplantation, Fundeni Clinical Institute, Bucharest, Romania, icfundeni.ro.

ORCID-Profile: Bogdan Marian Sorohan

Zitieren

APA

Cojocaru, M., Dumbravă, M., & Sorohan, B. M. (2026). Vedolizumab for De Novo Ulcerative Colitis After Kidney Transplantation in a Patient With IgA Nephropathy: A Case Report. Case Reports in Transplantation, 2026(1). https://doi.org/10.1155/crit/3572812

Vancouver

Cojocaru M, Dumbravă M, Sorohan BM. Vedolizumab for De Novo Ulcerative Colitis After Kidney Transplantation in a Patient With IgA Nephropathy: A Case Report. Case Reports in Transplantation. 2026;2026(1). doi:10.1155/crit/3572812

BibTeX
@article{Cojocaru2026,
  author = {Cojocaru, Monica and Dumbravă, Mona and Sorohan, Bogdan Marian},
  title = {Vedolizumab for De Novo Ulcerative Colitis After Kidney Transplantation in a Patient With IgA Nephropathy: A Case Report},
  journal = {Case Reports in Transplantation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crit/3572812}
}
Kostenlos starten →